Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02149901 · ClinicalTrials.gov registry record · Early Phase 1
Water and Sudafed in Autonomic Failure
A Early Phase 1 study, sponsored by Vanderbilt University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 35
- Enrollment target
NCT02149901: Clinical Trial Early Phase 1 study, sponsored by Vanderbilt University.
NCT02149901 is a Early Phase 1 study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 35 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02149901, a Early Phase 1 study, was terminated before completion, sponsored by Vanderbilt University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The specific aim of this study is to determine whether water ingestion potentiates the pressor response to pseudoephedrine in patients with primary disorders of autonomic failure. The study design will enable us to also evaluate the pressor response to water alone and to pseudoephedrine alone. In a secondary analysis, we will compare the results in patients with two autonomic disorders, pure autonomic failure (PAF) and multiple system atrophy (MSA). We hypothesize that drinking water following a dose of pseudoephedrine will lead to a greater increase in blood pressure than pseudoephedrine alone.
Interventions
- DRUG Pseudoephedrine + 480 ml water
- DRUG Pseudoephedrine + 50 ml water
- OTHER Placebo + 480 ml water (optional)
- OTHER Placebo + 50 ml water (optional)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-12 |
| Phase | Early Phase 1 |
Why NCT02149901 stopped before completion
NCT02149901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 4 interventions - of which Pseudoephedrine + 480 ml water is the first listed.
NCT02149901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02149901 about?
NCT02149901 is a clinical study titled "Water and Sudafed in Autonomic Failure". The specific aim of this study is to determine whether water ingestion potentiates the pressor response to pseudoephedrine in patients with primary disorders of autonomic failure. The study design will enable us to also evaluate the pressor response to water alone and to pseudoephedrine alone. In a ...
What is the current status of trial NCT02149901?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 35 participants. The study started on 2014-10. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02149901?
The interventions under investigation include: Pseudoephedrine + 480 ml water (DRUG), Pseudoephedrine + 50 ml water (DRUG), Placebo + 480 ml water (optional) (OTHER), Placebo + 50 ml water (optional) (OTHER).
Who is sponsoring clinical trial NCT02149901?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02149901's enrollment target sits among peer trials
35 735th of 2000 higher than 1,253 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia